Infectious keratitis treated with corneal crosslinking
- PMID: 21102196
- DOI: 10.1097/ICO.0b013e3181d2de91
Infectious keratitis treated with corneal crosslinking
Abstract
Purpose: To describe 7 eyes with severe infectious keratitis treated using collagen crosslinking (CXL) with riboflavin.
Materials and methods: Seven eyes of 6 patients with severe infectious keratitis were treated with corneal crosslinking. Three patients were contact lens users. Symptom duration before CXL ranged between 0 and 7 days. Corneal melting was present in all cases. Photodocumentation of the keratitis was carried out and repeated at follow-up. All but 1 patient received topical antibiotic treatment in addition to the CXL treatment. CXL was conducted according to the standardized protocol for keratoconus.
Results: In all but 1 eye, patients experienced improvement in symptoms within 24 hours. Two patients reported no symptoms whatsoever at this time. Corneal melting was arrested and complete epithelialization was achieved in all cases. In the 2 eyes with hypopyon, this regressed completely within 2 days after the CXL. Follow-up ranged between 1 and 6 months.
Discussion: Our experience based on the above and other cases suggest that CXL could be an effective tool in battling difficult cases of infectious keratitis. This treatment could present many advantages but will need further investigation.
Similar articles
-
PACK-CXL: defining CXL for infectious keratitis.J Refract Surg. 2014 Jul;30(7):438-9. doi: 10.3928/1081597X-20140609-01. J Refract Surg. 2014. PMID: 24983827 No abstract available.
-
Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation.J Cataract Refract Surg. 2014 Nov;40(11):1919-25. doi: 10.1016/j.jcrs.2014.09.001. Epub 2014 Sep 26. J Cataract Refract Surg. 2014. PMID: 25262564
-
Reply.Cornea. 2015 Nov;34(11):e35-6. doi: 10.1097/ICO.0000000000000594. Cornea. 2015. PMID: 26382892 No abstract available.
-
Corneal collagen cross-linking for infectious keratitis: an update of clinical studies.Acta Ophthalmol. 2015 Dec;93(8):689-96. doi: 10.1111/aos.12754. Epub 2015 May 19. Acta Ophthalmol. 2015. PMID: 25990098 Review.
-
Corneal Collagen Cross-linking: A Review of Clinical Applications.Asia Pac J Ophthalmol (Phila). 2015 Sep-Oct;4(5):300-6. doi: 10.1097/APO.0000000000000145. Asia Pac J Ophthalmol (Phila). 2015. PMID: 26381468 Review.
Cited by
-
Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents.Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1274-82. doi: 10.1167/iovs.14-16035. Invest Ophthalmol Vis Sci. 2015. PMID: 25634979 Free PMC article.
-
[Photodynamic therapy for infectious keratitis].Ophthalmologe. 2012 Feb;109(2):165-70. doi: 10.1007/s00347-011-2511-x. Ophthalmologe. 2012. PMID: 22350551 German.
-
Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivo.Sci Rep. 2017 Mar 15;7:44537. doi: 10.1038/srep44537. Sci Rep. 2017. PMID: 28295043 Free PMC article.
-
Accelerated vs. conventional collagen cross-linking for infectious keratitis.Exp Ther Med. 2021 Mar;21(3):285. doi: 10.3892/etm.2021.9716. Epub 2021 Jan 26. Exp Ther Med. 2021. PMID: 33603892 Free PMC article.
-
Photodynamic Therapy for Infectious Keratitis.Curr Ophthalmol Rep. 2020 Dec;8:245-251. doi: 10.1007/s40135-020-00252-y. Epub 2020 Sep 12. Curr Ophthalmol Rep. 2020. PMID: 34540359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical